Chuan Dai , Jinpeng Wang , Licheng Tu , Zhuoheng Pan , Jinru Yang , Shuang Zhou , Qinhong Luo , Lizhi Zhu , Yuxin Ye
{"title":"Genetically-encoded degraders as versatile modulators of intracellular therapeutic targets","authors":"Chuan Dai , Jinpeng Wang , Licheng Tu , Zhuoheng Pan , Jinru Yang , Shuang Zhou , Qinhong Luo , Lizhi Zhu , Yuxin Ye","doi":"10.1016/j.cobme.2023.100458","DOIUrl":null,"url":null,"abstract":"<div><p>Targeted protein degradation (TPD) is an emerging therapeutic approach that has attracted significant interest. The traditional TPD degraders rely on small molecules that can only target proteins of interest (POI) with known small-molecule binders or appropriate binding pockets. Recently, several genetic-encoded TPD (GE-TPD) strategies have been developed in which the degrader molecules are expressed in cells based on genetic information. GE-TPD discovers POI binders through techniques such as yeast and phage display and expands the E3 ligase toolbox through genetic encoding. In this review, we assess the progress of GE-TPD technologies in recent years and highlight innovative technologies that have the potential to advance the development of GE-TPD.</p></div>","PeriodicalId":36748,"journal":{"name":"Current Opinion in Biomedical Engineering","volume":"27 ","pages":"Article 100458"},"PeriodicalIF":4.7000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Opinion in Biomedical Engineering","FirstCategoryId":"5","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2468451123000144","RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Targeted protein degradation (TPD) is an emerging therapeutic approach that has attracted significant interest. The traditional TPD degraders rely on small molecules that can only target proteins of interest (POI) with known small-molecule binders or appropriate binding pockets. Recently, several genetic-encoded TPD (GE-TPD) strategies have been developed in which the degrader molecules are expressed in cells based on genetic information. GE-TPD discovers POI binders through techniques such as yeast and phage display and expands the E3 ligase toolbox through genetic encoding. In this review, we assess the progress of GE-TPD technologies in recent years and highlight innovative technologies that have the potential to advance the development of GE-TPD.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
